Developing The World’s First Medical Device
Therapy for Acute Pancreatitis
Developing The World’s First Device Therapy
for Acute Pancreatitis
Chill-AP Pivotal Study launching early 2026 based on completion of successful First in Human Study
Arctx Medical is focused on developing innovative medical device therapies to improve outcomes for patients suffering from Acute Pancreatitis
Non-Surgical. Minimally Invasive.
The Human Cost – Acute Pancreatitis
2.8 Million
cases of acute pancreatitis globally
Leading Cause of Hospitalization
amongst gastrointestinal disorders in the United States
No New Commercially Available Treatments for Acute Pancreatitis
Pain meds, fluids, and nutrition for mild cases
6 days
The average length of hospital stay
Prolonged Hospital Stay for Severe Pancreatitis
for 25% of pancreatitis patients